The Female Health Company announced the appointment of Brian J. Groch as Chief Commercial Officer, effective January 1, 2017. He will report to Mitchell Steiner, M.D., President and Chief Executive Officer of The Female Health Company. Groch will be responsible for all sales and marketing activities of the company, with the goal of coordinating prelaunch, launch, and sales and marketing activities to gain market share and drive business growth. He will develop, implement and manage the prescription products infrastructure for the overall commercial organization, including reimbursement, market access, payer policies, sales and marketing, inventory and distribution, trade, and customer service. In his new role as chief commercial officer, he will oversee all aspects of sales and marketing. Groch most recently served as Chief Commercial Officer of Telesta Therapeutics overseeing the global commercial strategy for the first new biologic for bladder cancer.